Enanta Pharmaceuticals Stock Market Value
| ENTA Stock | USD 8.56 0.45 4.99% |
| Symbol | Enanta |
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enanta Pharmaceuticals. If investors know Enanta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enanta Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Enanta Pharmaceuticals is measured differently than its book value, which is the value of Enanta that is recorded on the company's balance sheet. Investors also form their own opinion of Enanta Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Enanta Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enanta Pharmaceuticals' market value can be influenced by many factors that don't directly affect Enanta Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enanta Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Enanta Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enanta Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Enanta Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Enanta Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Enanta Pharmaceuticals.
| 12/08/2022 |
| 11/27/2024 |
If you would invest 0.00 in Enanta Pharmaceuticals on December 8, 2022 and sell it all today you would earn a total of 0.00 from holding Enanta Pharmaceuticals or generate 0.0% return on investment in Enanta Pharmaceuticals over 720 days. Enanta Pharmaceuticals is related to or competes with Monte Rosa, Design Therapeutics, Werewolf Therapeutics, Ikena Oncology, Stoke Therapeutics, Crinetics Pharmaceuticals, and Inhibrx. Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of ... More
Enanta Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Enanta Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Enanta Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.29) | |||
| Maximum Drawdown | 11.52 | |||
| Value At Risk | (4.76) | |||
| Potential Upside | 3.68 |
Enanta Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Enanta Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Enanta Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Enanta Pharmaceuticals historical prices to predict the future Enanta Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.17) | |||
| Jensen Alpha | (0.68) | |||
| Total Risk Alpha | (1.04) | |||
| Treynor Ratio | (1.46) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Enanta Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Enanta Pharmaceuticals Backtested Returns
Enanta Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.24, which denotes the company had a -0.24% return per unit of standard deviation over the last 3 months. Enanta Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Enanta Pharmaceuticals' Coefficient Of Variation of (421.04), standard deviation of 2.61, and Mean Deviation of 2.13 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.43, which means possible diversification benefits within a given portfolio. As returns on the market increase, Enanta Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Enanta Pharmaceuticals is expected to be smaller as well. At this point, Enanta Pharmaceuticals has a negative expected return of -0.62%. Please make sure to confirm Enanta Pharmaceuticals' coefficient of variation, value at risk, rate of daily change, as well as the relationship between the total risk alpha and kurtosis , to decide if Enanta Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.14 |
Insignificant predictability
Enanta Pharmaceuticals has insignificant predictability. Overlapping area represents the amount of predictability between Enanta Pharmaceuticals time series from 8th of December 2022 to 3rd of December 2023 and 3rd of December 2023 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Enanta Pharmaceuticals price movement. The serial correlation of 0.14 indicates that less than 14.0% of current Enanta Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.14 | |
| Spearman Rank Test | 0.17 | |
| Residual Average | 0.0 | |
| Price Variance | 3.63 |
Enanta Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Enanta Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Enanta Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Enanta Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Enanta Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Enanta Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Enanta Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Enanta Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Enanta Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Enanta Pharmaceuticals Lagged Returns
When evaluating Enanta Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Enanta Pharmaceuticals stock have on its future price. Enanta Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Enanta Pharmaceuticals autocorrelation shows the relationship between Enanta Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Enanta Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Enanta Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enanta Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enanta Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enanta Pharmaceuticals Stock:Check out Enanta Pharmaceuticals Correlation, Enanta Pharmaceuticals Volatility and Enanta Pharmaceuticals Alpha and Beta module to complement your research on Enanta Pharmaceuticals. For information on how to trade Enanta Stock refer to our How to Trade Enanta Stock guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Enanta Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.